You are here: Industry Insights > Abbott

News List

Abbott and the Abbott Fund donate $1 million to support Hurricane Harvey relief efforts worldpharmanews
September 01, 2017
Abbott (NYSE: ABT) and its foundation, the Abbott Fund, are providing $1 million in grants and healthcare and nutrition products to help deliver immediate relief following Hurricane Harvey and the devastating flooding affecting Texas and Louisiana.
Abbott introduces HeartMate 3 left ventricular assist system biospectrumasia
August 30, 2017
The HeartMate 3 system offers significant advancements, including a pump that is designed to reduce complications while improving survival and quality of life for patients with advanced heart failure.
Abbott’s nutrition metabolic formulas to help infants diagnosed with IEM expressbpd
August 18, 2017
Collaborates with healthcare providers, nutritionists and government to allow immediate availability, ensuring faster access to babies in need of critical nutrition
Abbott launches trial of transcatheter tricuspid repair device biospectrumasia
August 11, 2017
Abbott’s MitraClip has shown positive results for mitral regurgitation
Abbott Diabetes Care teams up with Bigfoot Biomedical to develop methods for diabetes management biospectrumasia
July 20, 2017
The next generation of Abott’s FreeStyle Libre glucose sensing technology will be given to Bigfoot so it can use...
Abbott’s new technology obtains Health Canada license biospectrumasia
July 04, 2017
With every scan, the system provides real-time glucose results, glucose direction, and eight-hour historical trend. The reader retains data for approximately 90 days.
Abbott announces CE Mark and first use of the world's first smartphone compatible insertable cardiac worldpharmanews
May 09, 2017
Abbott (NYSE: ABT) today announced CE Mark and first use of the new Confirm RxTM Insertable Cardiac Monitor (ICM), the world's first smartphone compatible ICM that will help physicians identify difficult to detect cardiac arrhythmias, including atrial fib
FDA approves Abbott’s molecular Zika virus test europeanpharmaceuticalreview
February 06, 2017
The US Food and Drug Administration (FDA) has authorised Abbott’s molecular test to detect Zika virus in whole blood (when collected alongside a patient-matched serum or plasma sample) for emergency use.
Abbott reports fourth-quarter 2016 results worldpharmanews
January 26, 2017
Abbott (NYSE: ABT) has announced that fourth-quarter 2016 worldwide sales of $5.3 billion increased 2.8 percent on a reported basis, including an unfavorable 1.0 percent effect of foreign exchange, and increased 3.8 percent on an operational basis.
Abbott Announces U.S. Launch and First Commercial Use of EnSite™ Precision Cardiac Mapping System americanpharmaceuticalreview
January 16, 2017
Abbott has announced the U.S. launch and the first commercial uses of the new EnSite Precision™ cardiac mapping system and Advisor™ FL Circular Mapping Catheter, Sensor Enabled™ to map cardiac arrhythmias during ablation treatments.

Previous page 1 2 3 4 5 6 7 Next page